(Q24248644)

1 July 2019

review article

1 reference

title

Amodiaquine for treating malaria (English)

1 reference

1 July 2019

0 references

0 references

2

Piero L Olliaro

1 reference

1 July 2019

author name string

Paola Mussano

series ordinal

1

1 reference

1 July 2019

language of work or name

English

0 references

publication date

22 April 2003

1 reference

1 July 2019

Cochrane Database of Systematic Reviews

published in

1 reference

1 July 2019

volume

2003

1 reference

1 July 2019

page(s)

CD000016

1 reference

29 July 2017

2

1 reference

1 July 2019

In vivo resistance of Plasmodium falciparum to 4-aminoquinolines and to a sulfadoxine-pyrimethamine combination. II--The Emperatriz study, Maranhâo, 1983-1984

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

Amodiaquine remains effective for treating uncomplicated malaria in west and central Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

In-vivo resistance of Plasmodium falciparum to chloroquine and amodiaquine in south Cameroon and age-related efficacy of the drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

Chemoresistance of Plasmodium falciparum in the urban region of Yaounde, Cameroon. Part 2: Evaluation of the efficacy of amodiaquine and sulfadoxine-pyrimethamine combination in the treatment of uncomplicated Plasmodium falciparum malaria in Yaounde

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

Resistance of Plasmodium falciparum to 3 antimalarials in Turbo (Antioquia, Colombia), 1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

In vivo efficacy study of amodiaquine and sulfadoxine/ pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

Comparative efficacy of alternative primary therapies for Plasmodium falciparum infections in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

The sensitivity of Plasmodium falciparum to chloroquine and amodiaquine in Ibadan, Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

Randomized comparison of chloroquine and amodiaquine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

Efficacy of amodiaquine against chloroquine-resistant malaria in Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

Gametocytaemia in Senegalese children with uncomplicated falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

Resistance of Plasmodium falciparum to antimalarial drugs in Equatorial Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

Drug-protein conjugates—XIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

7 January 2021

A comparison of amodiaquine and sulfadoxine-pyrimethamine as first-line treatment of falciparum malaria in Kenya

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

7 January 2021

Amodiaquine and chloroquine efficacy against Plasmodium falciparum in Madagascar

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

7 January 2021

Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

7 January 2021

Systematic review of amodiaquine treatment in uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

7 January 2021

Atovaquone and proguanil for Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

7 January 2021

Cutaneous disease and drug reactions in HIV infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

7 January 2021

Plasmodium falciparum in Madagascar: in vivo and in vitro sensitivity to seven drugs.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

7 January 2021

Evaluation of the relative efficacy of various antimalarial drugs in Nigerian children under five years of age suffering from acute uncomplicated falciparum malaria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

7 January 2021

In-vivo resistance of Plasmodium falciparum to chloroquine and amodiaquine in South Cameroon and age-related efficacy of the drugs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

7 January 2021

Stabilization of Drug Resistance (Chloroquine and Amodiaquine) of Plasmodium falciparum in Semiimmune Populations in the Congo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

7 January 2021

Ineffectiveness of amodiaquine against Plasmodium falciparum malaria in symptomatic young children living in an endemic malarious area of Papua New Guinea.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

7 January 2021

The disposition of amodiaquine in Zambians and Nigerians with malaria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

7 January 2021

Amodiaquine induced agranulocytosis and liver damage.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

7 January 2021

Immunogenicity of amodiaquine in the rat

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

7 January 2021

Amodiaquine and sulfadoxine-pyrimethamine as treatment for chloroquine-resistant Plasmodium falciparum in Rwanda

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000016

7 January 2021

10.1002/14651858.CD000016

Identifiers

DOI

1 reference

1 July 2019

OpenCitations bibliographic resource ID

2094394

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

1 July 2019

PubMed ID

12804382

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2094394

10796468

1 reference

PubMed ID

10796468